Screener
Jade Biosciences JBIO Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Jade Biosciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Jade Biosciences’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:27 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-212088
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Issuance costs from the December PIPE Financing | (809) | — |
| Issuance costs from the October PIPE Financing | (31) | — |
| Proceeds from stock option exercises | 45 | — |
| Net cash used in financing activities | (795) | (700) |
| Effect on exchange rates on cash and cash equivalents | (7) | — |
| Net decrease in cash and cash equivalents | (33,353) | (19,457) |
| Cash and cash equivalents at beginning of period | 88,438 | 69,386 |
| Cash and cash equivalents at end of period | $55,085 | $49,929 |
Item 1. Financial Statements.
FAQ
- What is Jade Biosciences's financing cash flow?
- Jade Biosciences (JBIO) reported financing cash flow of -$795K in Q1 2026.
- How has Jade Biosciences's financing cash flow changed year-over-year?
- Jade Biosciences's financing cash flow decreased by 13.6% year-over-year, from -$700K to -$795K.
- What is the long-term trend for Jade Biosciences's financing cash flow?
- Over 3 years (2021 to 2025), Jade Biosciences's financing cash flow has grown at a 23.7% compound annual growth rate (CAGR), from $190.71M to $360.77M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Jade Biosciences's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude